Lumexa Imaging (LMRI) vs Exagen (XGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Lumexa Imaging is the larger company by market cap ($1.02 billion vs $201.1 million), about 5.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMRI | XGN |
|---|---|---|
| Share price | $10.59 | $8.30 |
| Market cap | $1.02B | $201.07M |
| 1-day change | -1.12% | +1.34% |
| YTD return | -42.76% | +36.51% |
| 1-year return | — | -24.27% |
| 5-year return | — | -34.28% |
| Forward P/E | 11.90 | — |
| EPS (TTM) | $-0.37 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.45 | $12.23 |
| 52-week low | $6.45 | $2.59 |
| Distance from 52-week high | -45.55% | -32.13% |
| Average volume | 431.61K | 332.40K |
| Shares outstanding | 96.07M | 24.23M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Lumexa Imaging is about 5.1 times larger than Exagen by market value ($1.02B vs $201.07M).
LMRI vs XGN FAQ
Which is bigger, Lumexa Imaging or Exagen?
Lumexa Imaging (LMRI) is larger, with a market capitalization of $1.02B compared with $201.07M for Exagen (XGN).
Are Lumexa Imaging and Exagen in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.